You are here

Article Text

Article menu
Download PDFPDF
Archimedes
QUESTION 2: Does amoxicillin exposure increase the risk of rash in children with acute Epstein–Barr virus infection?
  1. Christine Chew,
  2. Anu Goenka
  1. Manchester Collaborative Centre for Inflammation Research, University of Manchester, Manchester, UK
  1. Correspondence to Dr Anu Goenka, Manchester Collaborative Centre for Inflammation Research, Grafton Street, University of Manchester, Manchester, M13 9NT, UK; anu.goenka{at}manchester.ac.uk
View Full Text

http://dx.doi.org/10.1136/archdischild-2015-310364

Statistics from Altmetric.com

    Question

    Does amoxicillin exposure increase the risk of rash in children with acute Epstein–Barr virus infection?

    Scenario

    You assess a 6-year-girl with tonsillitis. Group A beta-haemolytic streptococcus (GABHS) has been isolated from the throat swab. She was prescribed penicillin V, but is refusing to take this because she does not like the taste. Her mother is requesting a prescription for amoxicillin, which the girl has tolerated well previously. Your consultant is reluctant to prescribe amoxicillin, as he is concerned that it can precipitate rash if the underlying presentation is actually due to Epstein-Barr virus (EBV), with the isolation of GABHS reflecting commensal growth. You wonder how common an amoxicillin-related rash is in children with acute EBV.

    Structured clinical question

    In children with acute glandular fever (patient), does treatment with amoxicillin (intervention) increase the risk of rash (outcome)?

    Search strategy and outcome

    PubMed, Ovid and Cochrane were searched using the following terms: ‘infectious mononucleosis’ OR ‘Epstein-Barr virus’ OR ‘glandular fever’ AND ‘amoxicillin’ OR ‘ampicillin’ AND ‘cutaneous’ OR ‘eruption’ OR ‘rash’. The search returned a total of 31 publications. After the exclusion of case reports and review articles, five studies were found …

    View Full Text

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Copyright information:

    Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/